v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Preferred Shares
Warrants
Additional Paid-in-Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common Stock, Balance at beginning of period (in shares) at Dec. 31, 2020   31,816,020          
Balance at beginning of period at Dec. 31, 2020 $ 61,067 $ 32 $ 0 [1] $ 2,614 $ 213,624 $ (148,275) $ (6,928)
Preferred Stock, Balance at beginning of period (in shares) at Dec. 31, 2020 [1]     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (31,189)         (31,189)  
Exercise of options (in shares)   144,101          
Exercise of options 241       241    
Exercise of warrants (in shares)   794,804          
Exercise of warrants 151 $ 1   (1,241) 1,391    
Share-based compensation 948       948    
Common Stock, Balance at end of period (in shares) at Sep. 30, 2021   32,754,925          
Balance at end of period at Sep. 30, 2021 31,218 $ 33 $ 0 [1] 1,373 216,204 (179,464) (6,928)
Preferred Stock, Balance at end of period (in shares) at Sep. 30, 2021 [1]     0        
Common Stock, Balance at beginning of period (in shares) at Jun. 30, 2021   32,583,734          
Balance at beginning of period at Jun. 30, 2021 42,099 $ 33 $ 0 [1] 1,485 215,700 (168,191) (6,928)
Preferred Stock, Balance at beginning of period (in shares) at Jun. 30, 2021 [1]     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (11,273)         (11,273)  
Exercise of warrants (in shares)   171,191          
Exercise of warrants 27     (112) 139    
Share-based compensation 365       365    
Common Stock, Balance at end of period (in shares) at Sep. 30, 2021   32,754,925          
Balance at end of period at Sep. 30, 2021 $ 31,218 $ 33 $ 0 [1] 1,373 216,204 (179,464) (6,928)
Preferred Stock, Balance at end of period (in shares) at Sep. 30, 2021 [1]     0        
Common Stock, Balance at beginning of period (in shares) at Dec. 31, 2021 32,902,048 32,902,048          
Balance at beginning of period at Dec. 31, 2021 $ 19,073 $ 33 $ 0 [1] 1,373 216,685 (192,090) (6,928)
Preferred Stock, Balance at beginning of period (in shares) at Dec. 31, 2021 [1]     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (36,546)         (36,546)  
Issuance of common shares (in shares)   47,058,820          
Issuance of common shares 46,961 $ 47     46,914    
Issuance of warrants $ 0     9,775 (9,775)    
Shares issued for vested RSUs (in shares)   30,833          
Exercise of options (in shares) 0            
Exercise of warrants (in shares) 0            
Issuance of common shares under employee stock purchase plan (in shares)   53,995          
Issuance of common shares under employee stock purchase plan $ 77       77    
Share-based compensation $ 1,741       1,741    
Common Stock, Balance at end of period (in shares) at Sep. 30, 2022 80,045,696 80,045,696          
Balance at end of period at Sep. 30, 2022 $ 31,306 $ 80 $ 0 [1] 11,148 255,642 (228,636) (6,928)
Preferred Stock, Balance at end of period (in shares) at Sep. 30, 2022 [1]     0        
Common Stock, Balance at beginning of period (in shares) at Jun. 30, 2022   70,609,972          
Balance at beginning of period at Jun. 30, 2022 32,787 $ 71 $ 0 [1] 8,876 247,598 (216,830) (6,928)
Preferred Stock, Balance at beginning of period (in shares) at Jun. 30, 2022 [1]     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (11,806)         (11,806)  
Issuance of common shares (in shares)   9,411,765          
Issuance of common shares 9,760 $ 9     9,751    
Issuance of warrants 0     2,272 (2,272)    
Shares issued for vested RSUs (in shares)   23,959          
Share-based compensation $ 565       565    
Common Stock, Balance at end of period (in shares) at Sep. 30, 2022 80,045,696 80,045,696          
Balance at end of period at Sep. 30, 2022 $ 31,306 $ 80 $ 0 [1] $ 11,148 $ 255,642 $ (228,636) $ (6,928)
Preferred Stock, Balance at end of period (in shares) at Sep. 30, 2022 [1]     0        
[1] $0.001 par value, 10,000,000 shares authorized for all periods presented.